Henry Schein Inc. (HSIC) News

Henry Schein Inc. (HSIC): $79.75

0.10 (+0.13%)

POWR Rating

Component Grades













Filter HSIC News Items

HSIC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

HSIC News Highlights

  • For HSIC, its 30 day story count is now at 20.
  • Over the past 13 days, the trend for HSIC's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
  • DGX, CTLT and ABT are the most mentioned tickers in articles about HSIC.

Latest HSIC News From Around the Web

Below are the latest news stories about HENRY SCHEIN INC that investors may wish to consider to help them evaluate HSIC as an investment opportunity.

Illumina (ILMN) to Enable Tertiary Analysis With New Launch

Illumina's (ILMN) Connected Software is an end-to-end software system that standardizes analysis tools and connects data across the genomics workflow.

Yahoo | March 29, 2023

Surmodics (SRDX) Gets FDA's Formal Feedback About SurVeil DCB

Surmodics' (SRDX) receipt of the FDA's positive formal feedback regarding its PMA application for the SurVeil DCB looks promising.

Yahoo | March 29, 2023

Henry Schein Announces Presence at the 2023 Association of Dental Support Organizations (ADSO) Summit

MELVILLE, N.Y., March 28, 2023--Henry Schein, Inc. (Nasdaq: HSIC) announced its presence at the 2023 ADSO Annual Summit, including thought-leadership presentations on the future of dentistry and intrapreneurship as well as activities to support communities in need.

Yahoo | March 28, 2023

Reasons to Retain Quest Diagnostics (DGX) Stock for Now

Investors are optimistic about Quest Diagnostics (DGX) on solid fourth-quarter 2022 performance and its strategies to accelerate growth.

Yahoo | March 28, 2023

Is Henry Schein (HSIC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Yahoo | March 28, 2023

Quest Diagnostics (DGX) Introduces New Post-COVID-19 Panels

Quest Diagnostics' (DGX) latest panels provide consumers a deeper look into their health, helping to prepare them for meaningful discussions with their healthcare providers

Yahoo | March 27, 2023

MedTech Bigwigs in Spotlight as AI Revolutionizes Healthcare

MedTech player like Medtronic (MDT) are integrating artificial intelligence (AI) capabilities to aid therapeutic and diagnostic applications.

Yahoo | March 24, 2023

Catalent (CTLT) Inks Deal for Nasal Spray for Opioid Overdoses

Catalent's (CTLT) latest commercial supply agreement is expected to combat the opioid epidemic by making OTC naloxone more widely and easily accessible.

Yahoo | March 24, 2023

3 Reasons to Retain QuidelOrtho (QDEL) Stock in Your Portfolio

Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.

Yahoo | March 23, 2023

Quest Diagnostics (DGX) Advances Transplant Testing Service

These services by Quest Diagnostics (DGX) are available to recipients and living donors across the United States (excluding Alaska and Hawaii), broadening access for both donor and patient.

Yahoo | March 23, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.6677 seconds.